Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 1 - Studien 1 bis 3 von insgesamt 3
- Rekrutierung läuft
A phase 2b, randomized, blinded, placebo-controlled trial investigating the efficacy and safety of visugromab versus placebo, both in combination with pembrolizumab, pemetrexed, and cis-/carboplatin, in participants with newly diagnosed metastatic non-squamous non-small cell lung cancer (GDFATHER-LUNG-01)
- Rekrutierung läuftA phase 2b, randomized, blinded, placebo-controlled trial investigating the efficacy of visugromab plus nivolumab in combination with docetaxel versus docetaxel alone in metastatic non-squamous non-small-cell lung cancer (nsq-NSCLC) after failing one prior line of systemic treatment containing a checkpoint inhibitor for advanced/metastatic nsq-NSCLC
- Rekrutierung läuftA multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications. (PHOEBUS)Indikationen